|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 47/12 | |||
| A61K 31/485 | |||
| A61P 25/04 | |||
| A61P 25/36 |
| (11) | Number of the document | 2714018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12723144.7 |
| Date of filing the European patent application | 2012-05-14 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/058950 |
| Date | 2012-05-14 |
| (87) | Number | WO 2012/163665 |
| Date | 2012-12-06 |
| (30) | Number | Date | Country code |
| 102011076653 | 2011-05-27 | DE |
| (72) |
FAHRMEIR, Julia, DE
SCHURAD, Björn, DE
|
| (73) |
Luye Pharma AG,
Am Windfeld 35, 83714 Miesbach,
DE
|
| (54) | TRANSDERMALES THERAPEUTISCHES SYSTEM ENTHALTEND BUPRENORPHIN UND EINE ALPHA-HYDROXYSÄURE |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING BUPRENORPHIN COMPRISING A ALPHA-HYDROXY-ACID |